Review



anti cd86  (Bioss)


Bioz Verified Symbol Bioss is a verified supplier
Bioz Manufacturer Symbol Bioss manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 95

    Structured Review

    Bioss anti cd86
    Anti Cd86, supplied by Bioss, used in various techniques. Bioz Stars score: 95/100, based on 139 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+cd86/CD86+Polyclonal+Antibody/pm42988089-116-0-7
    Average 95 stars, based on 139 article reviews
    anti cd86 - by Bioz Stars, 2026-11
    95/100 stars

    Images

    Related Articles

    Incubation:

    Article Title: Possible Interaction of Suramin with Thalamic P2X Receptors and NLRP3 Inflammasome Activation Alleviates Reserpine-Induced Fibromyalgia-Like Symptoms.
    Article Snippet: .. After washing, the cells were incubated overnight at 4 °C with the following antibodies: anti-CD163 (Cat # GTX35247, GeneTex, CA, USA); anti-CD86 (Cat # bs- 1035R, Bioss, USA); and anti-CASPASE- 1 antibody (14 F468) [NB100 - 56565—1:100 Novus bio Co.]. .. The tissues were then treated with diaminobenzidine (DAB) for 10 min after rinsing with PBS, followed by incubation with the secondary antibody HRP EnVision reagent (DAKO) for an additional 20 min. After washing with PBS, the tissues were coverslipped for microscopic examination, counterstained with hematoxylin, dehydrated, and clarified in xylene.

    Article Title: Anti-inflammatory and antinociceptive effects of fasudil in a reserpine-induced fibromyalgia model: Role of ROCK-regulated leptin-STAT3 signaling.
    Article Snippet: Fibromyalgia (FM) is a chronic widespread pain syndrome driven by macrophage-mediated neuroinflammatory changes within the dorsal root ganglia (DRG), which initiate maladaptive neuroimmune signaling that promotes peripheral nociception and central sensitization.. Emerging evidence positions leptin and its downstream signaling networks as key regulators of nociceptive modulation and neuroinflammatory processes in chronic pain states.. Leptin, a pleiotropic adipocytokine, exerts potent pro-nociceptive effects at the peripheral sensory ganglia through ObRb receptor engagement and downstream JAK2–STAT3 activation, amplifying macrophage-driven neuroinflammation within the DRG and sustaining peripheral sensitization, yet this axis remains a largely unexplored therapeutic target.

    Article Title: Possible Interaction of Suramin with Thalamic P2X Receptors and NLRP3 Inflammasome Activation Alleviates Reserpine-Induced Fibromyalgia-Like Symptoms
    Article Snippet: .. After washing, the cells were incubated overnight at 4 °C with the following antibodies: anti-CD163 (Cat # GTX35247, GeneTex, CA, USA); anti-CD86 (Cat # bs- 1035R, Bioss, USA); and anti-CASPASE- 1 antibody (14 F468) [NB100 - 56565—1:100 Novus bio Co.]. .. The tissues were then treated with diaminobenzidine (DAB) for 10 min after rinsing with PBS, followed by incubation with the secondary antibody HRP EnVision reagent (DAKO) for an additional 20 min. After washing with PBS, the tissues were coverslipped for microscopic examination, counterstained with hematoxylin, dehydrated, and clarified in xylene.

    other:

    Article Title: Annexin A2 deficiency alleviates Mycoplasma ovipneumoniae induced lung inflammation damage by regulating ROS production.
    Article Snippet: Mycoplasma ovipneumoniae (MO) frequently induces severe oxidative damage to sheep lung tissue.. Annexin A2 (ANXA2) protein has been reported to serve as a receptor for multiple Mycoplasma species.. The present study aims to investigate whether ANXA2 can bind to MO and to elucidate its specific regulatory role in mediating MO infection and pathogenicity.

    Article Title: Stattic engineering M2 macrophage-derived exosomes mediate autophagy and immune reprogramming for secondary hyperparathyroidism
    Article Snippet: For IF, after incubation with goat anti-rabbit antibody for 30 min at room temperature, the cells were washed three times for 5 min in PBS, with the first wash containing 0.1 μg/mL DAPI (Thermo Scientific) or TUNEL (Servicebio, Beijing, China, LOT: G1501) for TUNEL detection assay, and mounted with Vectashield antifade mounting medium (Vector Labs, USA, LOT: H-1000) for microscopy.

    Blocking Assay:

    Article Title: Electroacupuncture normalized tumor vasculature by downregulating glyoxalase-1 to polarize tumor-associated macrophage to M1 phenotype in triple-negative breast cancer.
    Article Snippet: Background: Triple-negative breast cancer is a particularly aggressive type of breast cancer that is closely associated with abnormal vascularization within the tumor.. However, traditional anti-VEGF therapies and other treatments have limited efficacy.. Tumor-associated macrophages (TAMs) induce and regulate tumor angiogenesis.



    Similar Products

    95
    Bioss anti cd86
    Anti Cd86, supplied by Bioss, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+cd86/CD86+Polyclonal+Antibody/pm42988089-116-0-7
    Average 95 stars, based on 1 article reviews
    anti cd86 - by Bioz Stars, 2026-11
    95/100 stars
      Buy from Supplier

    94
    Miltenyi Biotec cd86
    EZH2 inhibition reduced the inflammatory phenotype of macrophages during OA. Macrophage differentiation and M1-like polarization were induced from the THP-1 monocytic cell line ( a ) or from human bone marrow-derived cells isolated from OA patients ( b ) in the presence or absence of EPZ-6438. The expression of pro-inflammatory markers (IL-1β, IL-6 and CXCL1) was analyzed by RT-qPCR. Experiments using THP-1 cells were independently repeated at least three times. Experiments using human bone marrow-derived cells were performed using biological replicates from independent OA patients. Data are presented as mean ± SEM. *: p -value < 0.05; **: p -value < 0.01; ***: p -value < 0.001. Spleens from OA mice described in Fig.  and treated with vehicle or EPZ-6438 were collected and analyzed by flow cytometry. Cells were stained for macrophage-associated markers ( c ). Samples were acquired using a FACSVerse flow cytometer and analyzed with FlowJo 7.6.5 software. Results are presented as median ± interquartile range (n = 8 mice). *: p -value < 0.05; **: p -value < 0.01
    Cd86, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+cd86/CD86+Antibody%2C+anti-mouse%2C+REAfinity/pmc13694607-279-27-31
    Average 94 stars, based on 1 article reviews
    cd86 - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    93
    Cytek Biosciences mouse cd86
    EZH2 inhibition reduced the inflammatory phenotype of macrophages during OA. Macrophage differentiation and M1-like polarization were induced from the THP-1 monocytic cell line ( a ) or from human bone marrow-derived cells isolated from OA patients ( b ) in the presence or absence of EPZ-6438. The expression of pro-inflammatory markers (IL-1β, IL-6 and CXCL1) was analyzed by RT-qPCR. Experiments using THP-1 cells were independently repeated at least three times. Experiments using human bone marrow-derived cells were performed using biological replicates from independent OA patients. Data are presented as mean ± SEM. *: p -value < 0.05; **: p -value < 0.01; ***: p -value < 0.001. Spleens from OA mice described in Fig.  and treated with vehicle or EPZ-6438 were collected and analyzed by flow cytometry. Cells were stained for macrophage-associated markers ( c ). Samples were acquired using a FACSVerse flow cytometer and analyzed with FlowJo 7.6.5 software. Results are presented as median ± interquartile range (n = 8 mice). *: p -value < 0.05; **: p -value < 0.01
    Mouse Cd86, supplied by Cytek Biosciences, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+cd86/In+Vivo+Ready+Anti-Mouse+CD86/pmc13748887-460-12-36
    Average 93 stars, based on 1 article reviews
    mouse cd86 - by Bioz Stars, 2026-11
    93/100 stars
      Buy from Supplier

    94
    Boster Bio 116 anti cd86
    EZH2 inhibition reduced the inflammatory phenotype of macrophages during OA. Macrophage differentiation and M1-like polarization were induced from the THP-1 monocytic cell line ( a ) or from human bone marrow-derived cells isolated from OA patients ( b ) in the presence or absence of EPZ-6438. The expression of pro-inflammatory markers (IL-1β, IL-6 and CXCL1) was analyzed by RT-qPCR. Experiments using THP-1 cells were independently repeated at least three times. Experiments using human bone marrow-derived cells were performed using biological replicates from independent OA patients. Data are presented as mean ± SEM. *: p -value < 0.05; **: p -value < 0.01; ***: p -value < 0.001. Spleens from OA mice described in Fig.  and treated with vehicle or EPZ-6438 were collected and analyzed by flow cytometry. Cells were stained for macrophage-associated markers ( c ). Samples were acquired using a FACSVerse flow cytometer and analyzed with FlowJo 7.6.5 software. Results are presented as median ± interquartile range (n = 8 mice). *: p -value < 0.05; **: p -value < 0.01
    116 Anti Cd86, supplied by Boster Bio, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+cd86/Anti-CD86+Antibody+Picoband/pm42977002-73-25-69
    Average 94 stars, based on 1 article reviews
    116 anti cd86 - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    95
    Bioss bs 1035r
    EZH2 inhibition reduced the inflammatory phenotype of macrophages during OA. Macrophage differentiation and M1-like polarization were induced from the THP-1 monocytic cell line ( a ) or from human bone marrow-derived cells isolated from OA patients ( b ) in the presence or absence of EPZ-6438. The expression of pro-inflammatory markers (IL-1β, IL-6 and CXCL1) was analyzed by RT-qPCR. Experiments using THP-1 cells were independently repeated at least three times. Experiments using human bone marrow-derived cells were performed using biological replicates from independent OA patients. Data are presented as mean ± SEM. *: p -value < 0.05; **: p -value < 0.01; ***: p -value < 0.001. Spleens from OA mice described in Fig.  and treated with vehicle or EPZ-6438 were collected and analyzed by flow cytometry. Cells were stained for macrophage-associated markers ( c ). Samples were acquired using a FACSVerse flow cytometer and analyzed with FlowJo 7.6.5 software. Results are presented as median ± interquartile range (n = 8 mice). *: p -value < 0.05; **: p -value < 0.01
    Bs 1035r, supplied by Bioss, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+cd86/CD86+Polyclonal+Antibody/pm42971140-104-43-41
    Average 95 stars, based on 1 article reviews
    bs 1035r - by Bioz Stars, 2026-11
    95/100 stars
      Buy from Supplier

    93
    Bio-Rad cd86
    Experimental timeline for calf vaccination, prescapular lymph node removal, and cannulation and in vitro expression of co-stimulatory and MHCII molecules in ALDCs stimulated with FMDV serotype O1 Campos. (A) Calves received a 2 ml dose of a commercial inactivated, oil-adjuvanted FMD vaccine containing four FMDV strains a few weeks after birth. Prescapular lymph nodes were then surgically removed (2–3 months after birth), and cannulation surgery was performed 2 months later. (B) Gating strategy. FSChigh/DEC205 cells were selected in the Q2 quadrant, followed by selection of DEC205/CD11c cells for analysis of co-stimulatory molecule expression. (C) Representative histograms showing surface expression of CD40, <t>CD86,</t> and MHCII (left to right). Solid line: mock; dotted line: infectious virus; light gray: inactivated virus; dark gray: Poly I:C (positive control). (D–F) Bar graphs represent the mean fluorescence intensity (MFI) ± SEM for ALDCs incubated with: culture medium (mock), inactivated FMDV (inactivated), infectious FMDV (infectious), or Poly I:C. D) CD40 (E) CD86 and (F) MHCII expression. *p < 0.05. **p < 0.01.
    Cd86, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+cd86/Mouse+anti+Rat+CD86/pmc13748441-70-5-8
    Average 93 stars, based on 1 article reviews
    cd86 - by Bioz Stars, 2026-11
    93/100 stars
      Buy from Supplier

    97
    Cell Signaling Technology Inc anti cd86
    Experimental timeline for calf vaccination, prescapular lymph node removal, and cannulation and in vitro expression of co-stimulatory and MHCII molecules in ALDCs stimulated with FMDV serotype O1 Campos. (A) Calves received a 2 ml dose of a commercial inactivated, oil-adjuvanted FMD vaccine containing four FMDV strains a few weeks after birth. Prescapular lymph nodes were then surgically removed (2–3 months after birth), and cannulation surgery was performed 2 months later. (B) Gating strategy. FSChigh/DEC205 cells were selected in the Q2 quadrant, followed by selection of DEC205/CD11c cells for analysis of co-stimulatory molecule expression. (C) Representative histograms showing surface expression of CD40, <t>CD86,</t> and MHCII (left to right). Solid line: mock; dotted line: infectious virus; light gray: inactivated virus; dark gray: Poly I:C (positive control). (D–F) Bar graphs represent the mean fluorescence intensity (MFI) ± SEM for ALDCs incubated with: culture medium (mock), inactivated FMDV (inactivated), infectious FMDV (infectious), or Poly I:C. D) CD40 (E) CD86 and (F) MHCII expression. *p < 0.05. **p < 0.01.
    Anti Cd86, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+cd86/CD86+Rabbit+mAb/10__1002_slash_imo2__70150-339-37-40
    Average 97 stars, based on 1 article reviews
    anti cd86 - by Bioz Stars, 2026-11
    97/100 stars
      Buy from Supplier

    96
    Proteintech rabbit anti cd86
    Experimental timeline for calf vaccination, prescapular lymph node removal, and cannulation and in vitro expression of co-stimulatory and MHCII molecules in ALDCs stimulated with FMDV serotype O1 Campos. (A) Calves received a 2 ml dose of a commercial inactivated, oil-adjuvanted FMD vaccine containing four FMDV strains a few weeks after birth. Prescapular lymph nodes were then surgically removed (2–3 months after birth), and cannulation surgery was performed 2 months later. (B) Gating strategy. FSChigh/DEC205 cells were selected in the Q2 quadrant, followed by selection of DEC205/CD11c cells for analysis of co-stimulatory molecule expression. (C) Representative histograms showing surface expression of CD40, <t>CD86,</t> and MHCII (left to right). Solid line: mock; dotted line: infectious virus; light gray: inactivated virus; dark gray: Poly I:C (positive control). (D–F) Bar graphs represent the mean fluorescence intensity (MFI) ± SEM for ALDCs incubated with: culture medium (mock), inactivated FMDV (inactivated), infectious FMDV (infectious), or Poly I:C. D) CD40 (E) CD86 and (F) MHCII expression. *p < 0.05. **p < 0.01.
    Rabbit Anti Cd86, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+cd86/CD86+Antibody/pm42914281-48-0-10
    Average 96 stars, based on 1 article reviews
    rabbit anti cd86 - by Bioz Stars, 2026-11
    96/100 stars
      Buy from Supplier

    95
    Elabscience Biotechnology fitc anti mouse cd86 antibodies
    Experimental timeline for calf vaccination, prescapular lymph node removal, and cannulation and in vitro expression of co-stimulatory and MHCII molecules in ALDCs stimulated with FMDV serotype O1 Campos. (A) Calves received a 2 ml dose of a commercial inactivated, oil-adjuvanted FMD vaccine containing four FMDV strains a few weeks after birth. Prescapular lymph nodes were then surgically removed (2–3 months after birth), and cannulation surgery was performed 2 months later. (B) Gating strategy. FSChigh/DEC205 cells were selected in the Q2 quadrant, followed by selection of DEC205/CD11c cells for analysis of co-stimulatory molecule expression. (C) Representative histograms showing surface expression of CD40, <t>CD86,</t> and MHCII (left to right). Solid line: mock; dotted line: infectious virus; light gray: inactivated virus; dark gray: Poly I:C (positive control). (D–F) Bar graphs represent the mean fluorescence intensity (MFI) ± SEM for ALDCs incubated with: culture medium (mock), inactivated FMDV (inactivated), infectious FMDV (infectious), or Poly I:C. D) CD40 (E) CD86 and (F) MHCII expression. *p < 0.05. **p < 0.01.
    Fitc Anti Mouse Cd86 Antibodies, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+cd86/FITC+Anti-Mouse+CD86+Antibody/pm42906800-82-32-37
    Average 95 stars, based on 1 article reviews
    fitc anti mouse cd86 antibodies - by Bioz Stars, 2026-11
    95/100 stars
      Buy from Supplier

    96
    Proteintech anti cd86
    Experimental timeline for calf vaccination, prescapular lymph node removal, and cannulation and in vitro expression of co-stimulatory and MHCII molecules in ALDCs stimulated with FMDV serotype O1 Campos. (A) Calves received a 2 ml dose of a commercial inactivated, oil-adjuvanted FMD vaccine containing four FMDV strains a few weeks after birth. Prescapular lymph nodes were then surgically removed (2–3 months after birth), and cannulation surgery was performed 2 months later. (B) Gating strategy. FSChigh/DEC205 cells were selected in the Q2 quadrant, followed by selection of DEC205/CD11c cells for analysis of co-stimulatory molecule expression. (C) Representative histograms showing surface expression of CD40, <t>CD86,</t> and MHCII (left to right). Solid line: mock; dotted line: infectious virus; light gray: inactivated virus; dark gray: Poly I:C (positive control). (D–F) Bar graphs represent the mean fluorescence intensity (MFI) ± SEM for ALDCs incubated with: culture medium (mock), inactivated FMDV (inactivated), infectious FMDV (infectious), or Poly I:C. D) CD40 (E) CD86 and (F) MHCII expression. *p < 0.05. **p < 0.01.
    Anti Cd86, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+cd86/CD86+Antibody/pm42895579-44-17-28
    Average 96 stars, based on 1 article reviews
    anti cd86 - by Bioz Stars, 2026-11
    96/100 stars
      Buy from Supplier

    Image Search Results


    EZH2 inhibition reduced the inflammatory phenotype of macrophages during OA. Macrophage differentiation and M1-like polarization were induced from the THP-1 monocytic cell line ( a ) or from human bone marrow-derived cells isolated from OA patients ( b ) in the presence or absence of EPZ-6438. The expression of pro-inflammatory markers (IL-1β, IL-6 and CXCL1) was analyzed by RT-qPCR. Experiments using THP-1 cells were independently repeated at least three times. Experiments using human bone marrow-derived cells were performed using biological replicates from independent OA patients. Data are presented as mean ± SEM. *: p -value < 0.05; **: p -value < 0.01; ***: p -value < 0.001. Spleens from OA mice described in Fig.  and treated with vehicle or EPZ-6438 were collected and analyzed by flow cytometry. Cells were stained for macrophage-associated markers ( c ). Samples were acquired using a FACSVerse flow cytometer and analyzed with FlowJo 7.6.5 software. Results are presented as median ± interquartile range (n = 8 mice). *: p -value < 0.05; **: p -value < 0.01

    Journal: Molecular Biomedicine

    Article Title: EZH2 coordinates inflammatory and pain-associated pathways across joint compartments in osteoarthritis

    doi: 10.1186/s43556-026-00643-w

    Figure Lengend Snippet: EZH2 inhibition reduced the inflammatory phenotype of macrophages during OA. Macrophage differentiation and M1-like polarization were induced from the THP-1 monocytic cell line ( a ) or from human bone marrow-derived cells isolated from OA patients ( b ) in the presence or absence of EPZ-6438. The expression of pro-inflammatory markers (IL-1β, IL-6 and CXCL1) was analyzed by RT-qPCR. Experiments using THP-1 cells were independently repeated at least three times. Experiments using human bone marrow-derived cells were performed using biological replicates from independent OA patients. Data are presented as mean ± SEM. *: p -value < 0.05; **: p -value < 0.01; ***: p -value < 0.001. Spleens from OA mice described in Fig. and treated with vehicle or EPZ-6438 were collected and analyzed by flow cytometry. Cells were stained for macrophage-associated markers ( c ). Samples were acquired using a FACSVerse flow cytometer and analyzed with FlowJo 7.6.5 software. Results are presented as median ± interquartile range (n = 8 mice). *: p -value < 0.05; **: p -value < 0.01

    Article Snippet: The following antibodies were used for immune cell characterization: CD11b (REA592 VioBlue, 130–113–810, Miltenyi Biotec), F4/80 (REA126 PE-Vio770, 130–118–459, Miltenyi Biotec), CD80 (REA983 APC-Vio770, 130–116–463, Miltenyi Biotec), CD86 (REA1190 PE, 130–122–129, Miltenyi Biotec), MHC-II (REA813 FITC, 130–112–386, Miltenyi Biotec), CD38 (REA616 PerCP-Vio700, 130–109–260, Miltenyi Biotec), and iNOS (REA982 APC, 130–116–423, Miltenyi Biotec).

    Techniques: Inhibition, Derivative Assay, Isolation, Expressing, Quantitative RT-PCR, Flow Cytometry, Staining, Software

    Experimental timeline for calf vaccination, prescapular lymph node removal, and cannulation and in vitro expression of co-stimulatory and MHCII molecules in ALDCs stimulated with FMDV serotype O1 Campos. (A) Calves received a 2 ml dose of a commercial inactivated, oil-adjuvanted FMD vaccine containing four FMDV strains a few weeks after birth. Prescapular lymph nodes were then surgically removed (2–3 months after birth), and cannulation surgery was performed 2 months later. (B) Gating strategy. FSChigh/DEC205 cells were selected in the Q2 quadrant, followed by selection of DEC205/CD11c cells for analysis of co-stimulatory molecule expression. (C) Representative histograms showing surface expression of CD40, CD86, and MHCII (left to right). Solid line: mock; dotted line: infectious virus; light gray: inactivated virus; dark gray: Poly I:C (positive control). (D–F) Bar graphs represent the mean fluorescence intensity (MFI) ± SEM for ALDCs incubated with: culture medium (mock), inactivated FMDV (inactivated), infectious FMDV (infectious), or Poly I:C. D) CD40 (E) CD86 and (F) MHCII expression. *p < 0.05. **p < 0.01.

    Journal: Frontiers in Immunology

    Article Title: Infectious and inactivated foot-and-mouth disease virus serotypes A/ARG/2001 and O1 Campos/Bra/58 differentially affect bovine afferent lymph dendritic cells

    doi: 10.3389/fimmu.2026.1909847

    Figure Lengend Snippet: Experimental timeline for calf vaccination, prescapular lymph node removal, and cannulation and in vitro expression of co-stimulatory and MHCII molecules in ALDCs stimulated with FMDV serotype O1 Campos. (A) Calves received a 2 ml dose of a commercial inactivated, oil-adjuvanted FMD vaccine containing four FMDV strains a few weeks after birth. Prescapular lymph nodes were then surgically removed (2–3 months after birth), and cannulation surgery was performed 2 months later. (B) Gating strategy. FSChigh/DEC205 cells were selected in the Q2 quadrant, followed by selection of DEC205/CD11c cells for analysis of co-stimulatory molecule expression. (C) Representative histograms showing surface expression of CD40, CD86, and MHCII (left to right). Solid line: mock; dotted line: infectious virus; light gray: inactivated virus; dark gray: Poly I:C (positive control). (D–F) Bar graphs represent the mean fluorescence intensity (MFI) ± SEM for ALDCs incubated with: culture medium (mock), inactivated FMDV (inactivated), infectious FMDV (infectious), or Poly I:C. D) CD40 (E) CD86 and (F) MHCII expression. *p < 0.05. **p < 0.01.

    Article Snippet: Mouse monoclonal antibodies against CD40, CD86, and MHCII (SEROTEC) were used, followed by the addition of anti- mouse IgG-Pe conjugated antibodies (BD).

    Techniques: In Vitro, Expressing, Selection, Analysis, Virus, Positive Control, Fluorescence, Incubation

    Expression of co-stimulatory and MHCII molecules in ALDCs stimulated with FMDV serotype A2001. (A) Gating strategy as shown in <xref ref-type=Figure 1A . (B) Representative histograms showing surface expression of CD40, CD86, and MHCII (left to right). Solid line: mock; dotted line: infectious virus; light gray: inactivated virus; dark gray: Poly I:C (positive control). (C–E) Bar graphs represent the mean fluorescence intensity (MFI) ± SEM for ALDCs incubated with: culture medium (mock), inactivated FMDV (inactivated), infectious FMDV (infectious), or Poly I:C. (C) CD40 (D) CD86 and (E) MHCII expression. *p < 0.05. **p < 0.01. " width="100%" height="100%">

    Journal: Frontiers in Immunology

    Article Title: Infectious and inactivated foot-and-mouth disease virus serotypes A/ARG/2001 and O1 Campos/Bra/58 differentially affect bovine afferent lymph dendritic cells

    doi: 10.3389/fimmu.2026.1909847

    Figure Lengend Snippet: Expression of co-stimulatory and MHCII molecules in ALDCs stimulated with FMDV serotype A2001. (A) Gating strategy as shown in Figure 1A . (B) Representative histograms showing surface expression of CD40, CD86, and MHCII (left to right). Solid line: mock; dotted line: infectious virus; light gray: inactivated virus; dark gray: Poly I:C (positive control). (C–E) Bar graphs represent the mean fluorescence intensity (MFI) ± SEM for ALDCs incubated with: culture medium (mock), inactivated FMDV (inactivated), infectious FMDV (infectious), or Poly I:C. (C) CD40 (D) CD86 and (E) MHCII expression. *p < 0.05. **p < 0.01.

    Article Snippet: Mouse monoclonal antibodies against CD40, CD86, and MHCII (SEROTEC) were used, followed by the addition of anti- mouse IgG-Pe conjugated antibodies (BD).

    Techniques: Expressing, Virus, Positive Control, Fluorescence, Incubation